In this episode of AI + a16z, General Partner Anjney Midha explains the forces that lead to GPU shortages and price spikes, and how the firm mitigates these concerns for portfolio companies by supplying them with the GPUs they need through a program called Oxygen. The TL;DR version of the problem is that competition for GPU access favors large incumbents who can afford to outbid startups and commit to long contracts; when startups do buy or rent in bulk, they can be stuck with lots of GPUs and — absent training runs or ample customer demand for inference workloads — nothing to do with them. Here is an excerpt of Anjney explaining how training versus inference workloads affect what level of resources a company needs at any given time:"It comes down to whether the customer that's using them . . . has a use that can really optimize the efficiency of those chips. As an example, if you happen to be an image model company or a video model company and you put a long-term contract on H100s this year, and you trained and put out a really good model and a product that a lot of people want to use, even though you're not training on the best and latest cluster next year, that's OK. Because you can essentially swap out your training workloads for your inference workloads on those H100s."The H100s are actually incredibly powerful chips that you can run really good inference workloads on. So as long as you have customers who want to run inference of your model on your infrastructure, then you can just redirect that capacity to them and then buy new [Nvidia] Blackwells for your training runs."Who it becomes really tricky for is people who bought a bunch, don't have demand from their customers for inference, and therefore are stuck doing training runs on that last-generation hardware. That's a tough place to be."Learn more:Navigating the High Cost of GPU ComputeChasing Silicon: The Race for GPUsRemaking the UI for AIFollow on X:Anjney MidhaDerrick Harris Check out everything a16z is doing with artificial intelligence here, including articles, projects, and more podcasts. Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
Dr. Erich G. Anderer, Chief of the Division of Neurosurgery and Surgical Director of Perioperative Services at NYU Langone Hospital–Brooklyn
09 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
Dr. Nolan Wessell, Assistant Professor and Well-being Co-Director, Department of Orthopedic Surgery, Division of Spine Surgery, University of Colorado School of Medicine
08 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-08-2025 1AM EST
08 Dec 2025
NPR News Now